MADRIGAL PHARMACEUTICALS, INC. Operating Lease, Liability, Current
MADRIGAL PHARMACEUTICALS, INC. (MDGL) had Operating Lease, Liability, Current of $1.03 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-07-30
- 2026-06-30: Operating Lease, Liability, Current $1.03M.
- 2026-03-31: Operating Lease, Liability, Current $1.70M.
- 2025-12-31: Operating Lease, Liability, Current $1.02M.
- 2025-09-30: Operating Lease, Liability, Current $1.08M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $1.03M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $1.70M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.02M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $1.08M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $1.05M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.02M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $983.00K 10-K · filed 2026-02-19 |
| 2024-09-30 | $878.00K 10-Q · filed 2024-10-31 |
| 2024-06-30 | $557.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $542.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $527.00K 10-K · filed 2025-02-26 |
| 2023-09-30 | $513.00K 10-Q · filed 2023-11-06 |
| 2023-06-30 | $411.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $653.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $602.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $760.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $879.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $413.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $410.00K 10-K/A · filed 2023-03-03 |
| 2021-09-30 | $406.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $403.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $320.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $318.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $315.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $323.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $319.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $315.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $310.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $306.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $302.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |